Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
Cited by 79
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
PTEN, PIK3CA, p-AKT, and p-p70S6K Status
|American Journal Of Pathology|2010|285
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
|Journal of Clinical Investigation|2017|231
ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells
|Cancer Research|2006|200
EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation
|Nature Communications|2022|190